Hypertension and Nephrology

Science News

First-Phase Ejection Fraction, a Measure of Preclinical Heart Failure, Is Strongly Associated With Increased Mortality in Patients With COVID-19 Hypertension | May 10, 2021

Cardiovascular Risk Factor Trajectories Since Childhood and Cognitive Performance in Midlife: The Cardiovascular Risk in Young Finns Study Circulation | May 10, 2021

Effects of Ambient Air Pollution on Blood Pressure Among Children and Adolescents: A Systematic Review and Meta‐Analysis Journal of the American Heart Association | May 04, 2021

Management of Stage 1 Hypertension in Adults With a Low 10-Year Risk for Cardiovascular Disease Hypertension | Apr 29, 2021

Some blood pressure meds may increase, while others lower, heart risks in people with HIV Hypertension | Apr 05, 2021

Journals

Team Science May 03, 2021 | Hypertension

FXYD1 Is Protective Against Vascular Dysfunction May 03, 2021 | Hypertension

Cigarette Smoking and Longitudinal Associations With Blood Pressure: The CARDIA Study Apr 27, 2021 | Journal of the American Heart Association

Antihypertensive Drugs for Secondary Prevention After Ischemic Stroke or Transient Ischemic Attack Apr 27, 2021 | Stroke

Time-Dependent Risk of Atrial Fibrillation in Patients With Primary Aldosteronism After Medical or Surgical Treatment Initiation Apr 19, 2021 | Hypertension

View Journals

Continuing Education

View Lifelong Learning catalog

Young male healthcare worker adjusts blood pressure cuff on the arm of an older male patient.

Hypertension 2021 new dates!

Join us virtually September 27–29, 2021

Expectations of the 2021 Program:

COH and KCVD Awards Program
Keynote Lecture
Clinical science and primary care sessions
Symposia on hot topics
Basic and translational science weighted toward presentations derived from submitted abstracts

Abstract submissions open through June 23, 2021 at 6:00 p.m. CDT

We know this has been an exceptionally challenging year in so many ways. We want to recognize all the research and clinical work that has been performed during this difficult time. Therefore, attendees can expect that the program will be dedicated to important and innovative clinical topics in hypertension as well as research performed by our members and attendees. The latter will primarily include abstract presentations.

The Hypertension Council fosters excellence in hypertension research and education in support of the AHA’s mission. Hypertension remains a world-wide public-health challenge and is a leading cause of stroke, heart disease, and the progression of chronic kidney disease. The annual Hypertension Scientific Sessions showcases timely research.

Hypertension Scientific Sessions

Hypertension Journal

Hypertension Council Awards

The KCVD Council works to reduce cardiovascular-related disability and death through research, communication, advocacy, and education about the kidney. Kidney disease is a major cause and consequence of cardiovascular disease. Chronic renal insufficiency can contribute to development of hypertension, vascular disease, atherosclerosis and other morbidity and mortality risk factors.

Hypertension Scientific Sessions

Hypertension Journal

KCVD Council Awards

Hypertension and Nephrology

Science News

Journals

Continuing Education

Hypertension 2021 new dates!

Council on Hypertension

Council on the Kidney in Cardiovascular Disease

Hypertension and Nephrology

FIDELIO DKD Results

Science News

Journals

Continuing Education

Hypertension 2021 new dates!

Council on Hypertension

Council on the Kidney in Cardiovascular Disease

American Heart Association Professional Members